24 /100
LOW RISK
Score updated Jul 13, 2026

USPH — U.S. Physical Therapy, Inc. Dilution Risk Tracker

Track USPH dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track USPH — Get alerts when the score changes →

As of July 13, 2026, U.S. Physical Therapy, Inc. (USPH) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. U.S. Physical Therapy, Inc. has a market capitalization of $977.96M, 15.22M shares outstanding, 231 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for USPH.
🔔 Track USPH — Get forecast alerts →

💹 Market Data

Market Cap$977.96M
Shares Outstanding15.22M
Float14.85M
Cash$28.44M
Debt$204.84M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 19.6% shares (2026Q1 vs prior)
231 institutional holders · 19.78M shares
#1 MORGAN STANLEY 3.14M shares
#2 BlackRock, Inc. 2.21M shares
#3 VANGUARD CAPITAL MANAGEMENT LLC 1.33M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest1.06M
Days to Cover4.7
% of Float7.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

4 INSIDER TRANSACTION Mar 12, 2026
4 INSIDER TRANSACTION Mar 11, 2026
4 INSIDER TRANSACTION Mar 10, 2026
4 INSIDER TRANSACTION Mar 09, 2026
4 INSIDER TRANSACTION Feb 25, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for USPH Shareholders

U.S. Physical Therapy, Inc. (USPH) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for USPH shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for USPH in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for USPH alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track USPH Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking USPH — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for USPH
📊 USPH FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 USPH Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.